Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes
- 1 February 1986
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 29 (2) , 218-223
- https://doi.org/10.1021/jm00152a009
Abstract
A series of gold(I) coordination complexes including analogues of the antiarthritic agent auranofin 1 were evaluated for in vitro cytotoxic potency against both B16 melanoma cells and P388 leukemia cells and in vivo antitumor activity against P388 leukemia in mice. A number of the complexes showed potent cytotoxic activity in vitro and antitumor activity in vivo, with the phosphine-coordinated gold(I) thiosugar complexes demonstrating the greatest in vitro and in vivo activity. The data compiled for 63 complexes of the general structural formula LAuX provide the basis for the following observations: (1) potent in vitro cytotoxic activity is observed for substituted (phosphine)gold complexes, (2) lack of potency in vitro correlates well with lack of antitumor activity, (3) potent cytotoxicity in vitro is not necessarily predictive of activity in vivo, (4) in vivo antitumor activity is generally optimized by ligation of Au(I) with a substituted phosphine and a thiosugar.This publication has 11 references indexed in Scilit:
- Effects of coordinated gold compounds on in vitro and in situ DNA replicationBiochemical Pharmacology, 1985
- A 1H nmr study of the interaction of aurothiomalate (“Myocrisin”) with human red blood cells in vitroJournal of Inorganic Biochemistry, 1983
- In vitro responses of human prostate tumour cell lines to a range of antitumour agentsInternational Journal of Cancer, 1983
- Synthesis of 195Au, 32P and 35S-labelled auranofin, A novel orally effective gold antiarthritic drugJournal of Labelled Compounds and Radiopharmaceuticals, 1983
- SCREENING TRIAL WITH THE COORDINATED GOLD COMPOUND AURANOFIN USING MOUSE LYMPHOCYTIC LEUKEMIA-P3881981
- Rhodium (II) Butyrate: A Potential Anticancer Drug With Cell Cycle Phase-Specific Effects in HeLa Cells2JNCI Journal of the National Cancer Institute, 1980
- PHASE-I CLINICAL-TRIAL OF SPIROGERMANIUM1980
- Inhibitory effects of a new oral gold compound on hela cellsCancer, 1979
- Platinum and palladium derivatives for chemotherapy studiesJournal of Medicinal Chemistry, 1979
- EFFECT OF AURANOFIN ON DNA AND PROTEIN-SYNTHESIS IN HUMAN LYMPHOCYTES1977